CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Predictors of relapse in genotype 1 patients treated with PegIFN-alfa2b and ribavirin due to chronic hepatitis C within a large German multicentric observational study
DOI 10.1055/s-0028-1089437
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Mauss, D Hueppe, M Manns, G Teuber, T Dahhan, S Kaiser, U Meyer, T Witthöfft, R Mendel, B Möller, N Dikopoulos, J Brack, G Tossing, M Bilzer, E Zehnter
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Late treatment failure in chronic hepatitis C (CHC), defined as relapse during follow-up after an end-of-treatment response, occurs in up to 30% of patients treated with a standard combination therapy of pegylated IFN-alfa and ribavirin (Caliceti P, Dig Liver Dis 2004; 36, Suppl. 3: 334–339). Thus far, only hcv-genotype, age, dose of ribavirin and duration of infection have been proposed as predictors of relap…
Zitieren
Zitierempfehlung
S Mauss, D Hueppe, M Manns, G Teuber, T Dahhan, S Kaiser, U Meyer, T Witthöfft, R Mendel, B Möller, N Dikopoulos, J Brack, G Tossing, M Bilzer, E Zehnter (2008) Predictors of relapse in genotype 1 patients treated with PegIFN-alfa2b and ribavirin due to chronic hepatitis C within a large German multicentric observational study. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0028-1089437
Mit CareLit weiterarbeiten